Ummino going global with gut health supplement
This NC State spinout that has licensed technology from Dr. José Bruno-Bárcena's lab.
The following is an excerpt from an article originally written by Jim Shamp, and published by the NC Biotechnology Center. Read the full original article.
Hippocrates, the “father of modern medicine,” is credited with the admonition that “Our food should be our medicine, and our medicine should be our food.”
Embracing that belief, a North Carolina State University spinout company founded in 2019 is launching a new kind of “boost” to foods and beverages that captures unique and elusive benefits in human breast milk, to maximize gut health.
The Durham company, Ummino, is targeting the sharp rise in consumer demand for fortified food and beverage products. Its patented precision fermentation technology uses a yeast-bound recombinant enzyme to biomanufacture a human milk oligosaccharide prevalent in breast milk, and a prebiotic that previously couldn’t be produced at commercial scale.
Ummino has figured out how to produce this precious commodity in large quantities so food producers can incorporate it into the products they sell around the world.
Ummino’s technology platform originated with research and innovation developed at NC State by cofounder and Chief Science Officer Jose Bruno, Ph.D. The company is also partnering with the University of North Carolina at Chapel Hill on a human safety clinical trial through another cofounder, Andrea Azcarate, Ph.D., director of UNC’s Microbiome Core Research Program.
- Categories:
